CF33-hNIS-antiPDL1

· City of Hope Medical Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CF33-hNIS-antiPDL1, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer [Phase 1]